Founded in Aurora, Colorado, aiGENE is a medical organization dedicated to revolutionizing cancer diagnostics and treatment monitoring. Their core mission is to provide rapid, inexpensive, and universal blood tests that measure both the presence of cancer and the efficacy of cancer therapies. aiGENE's vision is to make pan-cancer monitoring and screening accessible and effective for all, ultimately improving patient outcomes through actionable information derived from their proprietary epigenetic technology.

Notable individuals affiliated with aiGENE include Floyd Taub, whose leadership drives the company's innovative approach. The company has achieved significant milestones, including the development of a rapid pan-cancer blood test that offers real-time insights into cancer treatment effectiveness. aiGENE's impact lies in its potential to transform cancer care by providing a cost-effective, universal solution for early detection and ongoing monitoring, thereby enhancing the precision and personalization of cancer treatment.